Hoori Aslroosta

Hoori Aslroosta

Auto-generated profile, based on publicly available information

Hoori Aslroosta

Department of Periodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
GMGhazal Morshedzadeh
Ghazal Morshedzadeh
HAHoori Aslroosta
Hoori Aslroosta
MVMahsa Vafaei
Mahsa Vafaei
Background: The aim of this study was to evaluate the effects of photobiomodulation (PBM) on wound healing, pain, and discomfort at free gingival graft (FGG) donor sites. Methods: Sixteen patients in need of bilateral FGG were selected for this randomized, controlled, triple-blinded, and split mouth clinical trial. The FGG donor sites in test group were treated with LLLT GaAlAs 940 nm, 5 J/cm2 immediately after surgery and every other day within the following ten days. The control group received sham irradiation. Remaining Wound Area (RWA), Epithelialization and color match were evaluated on the day of surgery and 7, 14, 21, 28, and 60 days after surgery. A questionnaire was administered to measure pain and bleeding in the first ten days after surgery. Results: RWA was significantly smaller in the test than control group on the days 7 (p < 0.001) and 14 (p = 0.048) after the surgery. Bleeding was higher in the test group than in the control group on the day of surgery (p = 0.046). Pain and discomfort at the palatal donor site, however, had no significant difference between laser and control group during 11 days after the surgery (p > 0.05), nor did the Color match scores on the 28th and 60th days after the surgery (p > 0.05). Conclusions: It can be concluded that PBM enhances FGG donor site wound healing one and two weeks after the surgery. Trial registration IRCT2017092036203N2, registered 01.11.2017.

18 December 2019 in Journal of Advanced Periodontology & Implant Dentistry
Verified
Journal Article
Open access
PDF file
SYSiamak Yaghobee
Siamak Yaghobee
FDFarid Abedin Dorkoosh
Farid Abedin Dorkoosh
FKFarnaz Kouhestani
Farnaz Kouhestani
GMGhazaleh Mozafari
Ghazaleh Mozafari
HAHoori AslRoosta
Hoori AslRoosta
Background. Chemical plaque control, an adjunct to mechanical approaches, could improve the maintenance of patients with different types of periodontitis. Chlorhexidine, the gold standard in chemical plaque control, might have some side effects; the most determining one is tooth discoloration. Anti-discoloration systems (ADS) have been added to minimize brownish tooth discoloration. This study aimed to evaluate the staining potential and clinical efficacy of chlorhexidine with and without ADS in patients with chronic periodontitis. Methods. In this randomized controlled trial, 46 patients with chronic periodontitis were randomly allocated to two groups. Each patient used 10 mL of mouthwash A (CHX without ADS) or B (CHX with ADS, including sodium metabisulfite and ascorbic acid) twice a day for two weeks. After a two-week interval, they used the second mouthwash. At the beginning and the end of each two-week cycle, plaque index (PI), bleeding on probing (BoP), and staining index were recorded. Results. There was no significant difference between mouthwash A and B in the reduction of BoP and PI. The staining index was significantly lower after rinsing with mouthwash B compared to mouthwash A. Conclusion. CHX mouthwash containing ADS has similar efficacy in microbial plaque control and reduction of BOP as CHX without ADS, with the advantage of lower stain formation on tooth surfaces in patients with chronic periodontitis.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SYShima Younespour
Shima Younespour
SYSiamak Yaghobee
Siamak Yaghobee
HAHoori Aslroosta
Hoori Aslroosta
NMNeda Moslemi
Neda Moslemi
EPElham Pourheydar
Elham Pourheydar
EGElaha Somaya Ghafary
Elaha Somaya Ghafary
Purpose. This study is aimed at synthesizing the available evidence regarding effectiveness of various modalities (combinations of LRS tasks) and comparison between each two modalities in terms of gingival display reduction, success rate, stability of the results, patient’s satisfaction, and postoperative morbidity. Materials and Methods. The electronic databases including PubMed, Scopus, Web of Science Cochrane Library, Google Scholar databases, ClinicalTrials.gov, and WHO International Clinical Trial Registry Platform were searched up to 27th June 2020 regarding lip repositioning surgery. The modalities were defined as the combinations of the following tasks: frenectomy (yes/no), flap thickness (full/partial), and myotomy (yes/no). Meta‐analyses were performed on gingival display change from baseline to months 3, 6, and 12 in each modalities using Stata (v.16). Results. 38 studies (including three clinical trials, two quasiexperimental studies, seven case series, and 26 case reports) met the criteria for final inclusion. The mean gingival display reduced from baseline to 6 months (WMD = −2.90, 95% CI: ‐4.85 to ‐0.95) in the patients undergoing the “frenectomy + full‐thickness flap + myotomy” modality. This parameter decreased from baseline to 6 and 12 months, respectively (WMD = −2.68, 95% CI: ‐3.49 to ‐1.86; WMD = −2.52, 95% CI: ‐4.40 to ‐0.64), in patients undergoing the “frenectomy + partial‐thickness flap + without myotomy” modality. In patients who undergone the “without frenectomy + partial‐thickness flap + without myotomy” modality, gingival display reduced from baseline to 6 months (WMD = −3.22, 95% CI: ‐5.61 to ‐0.84). Almost 83% of patients with modality 1 had satisfaction. Conclusions. Gingival display within the 6 months after LRS could be reduced with all modalities. Descriptively, the greatest reduction was observed in patients with the modality not including the frenulum.

12 November 2021 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
SYSiamak Yaghobee
Siamak Yaghobee
NRNina Rouzmeh
Nina Rouzmeh
MTMina Taheri
Mina Taheri
HAHoori Aslroosta
Hoori Aslroosta
SMSanaz Mahmoodi
Sanaz Mahmoodi
AKAfshin Khorsand
Afshin Khorsand
Background: Free gingival graft (FGG) is a highly predictable method to increase the width of keratinized gingiva. Various materials have been reported to accelerate the wound healing process. Considering the positive effect of EPO on dermal wound healing this study aimed to investigate the effects of EPO on the rate of healing and degree of inflammation in free gingival grafts. Methods: Seventeen patients with bilateral lack of keratinized gingiva in mandible were selected for this clinical trial. The surgical intervention was performed after phase I periodontal therapy. Recipient site was prepared apical to the mucogingival line, and FGG was harvested from the palate. Before graft placement, the test side and control side were treated with 1 ml of EPO 4000 IU/ml and distilled water, respectively, for 2 min. On days 7, 14, 21, 28, 60, and 90 after surgery, the grafted sites were examined by blinded observers to compare the healing and inflammation of the areas. Results: All the 17 patients completed the surgeries and follow-up examinations. Direct examination revealed significantly better healing in EPO group only on the 28th day. Assessment of the photographs showed a significant value in favor of the test group at some other time points as well. The EPO group demonstrated less inflammation, which was statistically significant in many time points. The graft area was 80.88 ± 30.21 mm2 and 71.35 ± 15.62 mm2 in the EPO and control groups, respectively. The difference was not significant, though. Conclusions: Topical application of erythropoietin can accelerate the healing of gingival grafts and reduce the inflammation during healing period. The final graft outcome, nevertheless, does not seem to be influenced by EPO. Trial registration This was a split-mouth randomized controlled clinical trial (IRCT201201278830N1). The first registration date: 2016-10-22


23 February 2022 in Research Square
Verified
Preprint
Open access
PDF file
GTGhazal Morshedzadeh Tehrani
Ghazal Morshedzadeh Tehrani
HAHoori Aslroosta
Hoori Aslroosta
MVMahsa Vafaei
Mahsa Vafaei
Background: The aim of this study was to evaluate the effects of photobiomodulation (PBM) on wound healing, pain, and discomfort at free gingival graft (FGG) donor sites.Methods: Sixteen patients in need of bilateral FGG were selected for this randomized, controlled, triple-blinded, and split mouth clinical trial. The FGG donor sites in test group were treated with LLLT GaAlAs 940nm, 5J/cm2 immediately after surgery and every other day within the following ten days. The control group received sham irradiation. Remaining Wound Area (RWA), Epithelialization and color match were evaluated on the day of surgery and 7, 14, 21, 28, and 60 days after surgery. A questionnaire was administered to measure pain and bleeding in the first ten days after surgery. Results: RWA was significantly smaller in the test than control group on the days 7 (P 0.05), nor did the Color match scores on the 28th and 60th days after the surgery (P> 0.05). Conclusions: It can be concluded that PBM enhances FGG donor site wound healing one and two weeks after the surgery.Trial registration: IRCT2017092036203N2, registered 01.11.2017.